Search

Palvella Therapeutics Inc

Lezárt

SzektorEgészségügy

145.22 -5.87

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

144.71

Maximum

151.36

Fő mutatók

By Trading Economics

Bevétel

-6.1M

-22M

Munkavállalók

29

EBITDA

-5.8M

-20M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+58.57% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 5.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-129M

1.6B

Előző nyitás

151.09

Előző zárás

145.22

Palvella Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. okt. 30. 23:51 UTC

News

FMC Corp shares are declining in after-market hours following disappointing Q3 earnings, with an 80% revenue drop to $106 million and an adjusted loss per share of $4.41.

2026. okt. 30. 23:51 UTC

News

BTIG suspended its Buy rating on Zoetis Inc, contributing to a modest decline in the stock during after-market hours.

2026. okt. 30. 23:51 UTC

News

Stryker receives mixed analyst assessments, with Stifel lowering its price target to $325 and Citigroup adjusting to $315, both maintaining Buy ratings.

2026. okt. 30. 23:41 UTC

News

Allegro Microsystems Inc. reported Q2 FY27 sales of $276.88M, exceeding expectations, and provided Q3 guidance of $278M to $288M, with shares modestly higher in after-market trading.

2026. okt. 30. 23:41 UTC

News

BTIG suspended its Buy rating on IDEXX Laboratories, contributing to a decline in the stock's price during after-market hours.

2026. okt. 30. 23:36 UTC

News

Capri Holdings Ltd reported Q2 profit of 42 cents per share and raised full-year EPS forecast to $2.20, with shares trading lower in after-market hours.

2026. okt. 30. 23:31 UTC

News

McGrath RentCorp will replace Glaukos in the S&P 600 index at the market open on November 4, 2026, contributing to positive after-market price movement.

2026. okt. 30. 23:26 UTC

News

JP Morgan maintains its Underweight rating on T. Rowe Price while raising the price target to $107; TD Cowen lowers its target to $96.

2026. okt. 30. 23:26 UTC

News

Citigroup reaffirms Buy rating on Fortrea Holdings Inc and raises price target to $27, according to a report published today.

2026. okt. 30. 23:21 UTC

News

Compass Inc. faces a class action lawsuit from Pomerantz LLP, alleging securities fraud related to its merger with Anywhere Real Estate Inc.

2026. okt. 30. 23:16 UTC

News

JP Morgan maintains Neutral rating on Dexcom Inc and raises its price target to $85, reflecting the company's market position and growth potential.

2026. okt. 30. 23:11 UTC

News

Pomerantz LLP has filed a class action lawsuit against The Chemours Company, alleging misleading statements and violations of federal securities laws.

2026. okt. 30. 23:11 UTC

News

Cantor Fitzgerald identifies Binance's $6.3 billion hack as a potential buying opportunity for crypto-linked stocks, including Strategy Inc., amid recovery confidence.

2026. okt. 30. 23:06 UTC

News

Uranium Energy Corp. shares declined in after-market hours, reflecting broader sector pressures despite analysts noting tightening supply in the uranium market.

2026. okt. 30. 23:06 UTC

News
Social Media

S&P Global Ratings revised its outlook on Meta Platforms, Inc. to negative, citing uncertainty over capital expenditures and projected free operating cash flow deficits.

2026. okt. 30. 23:06 UTC

News
Social Media

eBay expands managed shipping program amid seller eligibility concerns.

2026. okt. 30. 23:06 UTC

News
Social Media

Coinbase Global, Inc. received an Overweight rating from JP Morgan, which lowered its price target to $187 amid security concerns following the $6.3 billion Binance hack.

2026. okt. 30. 23:06 UTC

News

Starbucks plans to trial an AI-driven "fast pass" feature for drive-throughs to enhance customer experience, leveraging its app and loyalty program.

2026. okt. 30. 23:06 UTC

News

Kraft Heinz Company shares are trading modestly higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month range.

2026. okt. 30. 23:06 UTC

News

The Hershey Company is trading higher in after-market hours, following analysts' adjustments with Evercore ISI lowering its price target to $200 and TD Cowen maintaining $198.

2026. okt. 30. 23:06 UTC

News

DraftKings Inc. shares declined in after-market trading, pulling back from earlier gains as investors anticipate an upcoming earnings report amid ongoing pressure.

2026. okt. 30. 23:06 UTC

News

Celsius Holdings faces a class action lawsuit from Pomerantz LLP over alleged federal securities law violations related to its Alani Nu energy drinks' marketing practices.

2026. okt. 30. 23:06 UTC

News

Citigroup maintains a Neutral rating on Enphase Energy and lowers its price target to $25, which may have influenced investor sentiment.

2026. okt. 30. 23:06 UTC

Correlated Moves
News

Ares Capital Corp announces a merger agreement to acquire MidCap Financial Investment Corporation, leading to the cancellation of MidCap's earnings call on November 5, 2026.

2026. okt. 30. 23:02 UTC

Macro News
News

Bitcoin has declined below $77K following a significant security breach at Binance, resulting in the theft of approximately $6.3 billion and raising cybersecurity concerns.

2026. okt. 30. 23:01 UTC

News

Dyadic International Inc will report its Q3 2026 financial results and host a conference call on November 12, 2026, to enhance investor transparency.

2026. okt. 30. 23:01 UTC

News

Rivian Automotive reported Q3 revenue of $2.15 billion and raised full-year delivery guidance to 67k units, despite shares falling in after-market trading.

2026. okt. 30. 23:01 UTC

News

BWX Technologies Inc. is rising in after-market trading after being selected by the U.S. Army for a $2.2 billion nuclear microreactor project.

2026. okt. 30. 23:01 UTC

News

JP Morgan maintains Neutral rating on Republic Services and raises price target to $265, following an update published after the market close.

2026. okt. 30. 23:01 UTC

News

Twilio Inc. is under investigation by Levi & Korsinsky for potential federal securities law violations related to its lowered Q4 revenue growth guidance.

Társak összehasonlítása

Árváltozás

Palvella Therapeutics Inc Előrejelzés

Célár

By TipRanks

58.57% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 231.75 USD  58.57%

Magas 267 USD

Alacsony 207 USD

13 Wall Street elemző 12 hónapos célárain alapulva a(z)Palvella Therapeutics Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

13 ratings

13

Vétel

0

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Adózás előtti nyereség

Értékesítés

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

help-icon Live chat